HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells.

Abstract
Retinoic acid receptor alpha (RARalpha) plays an important role in mediating all-trans retinoic acid (ATRA) signals. In this study, we found that ATRA up-regulated RARalpha mRNA and protein expression in gastric cancer BGC-823 cells. However, in breast cancer MCF-7 cells it down-regulated RARalpha protein expression with no effect on its RARalpha mRNA. Immunoprecipitation/Western blot analysis showed that, although sumoylated and ubiquitinated RARalpha existed simultaneously in both cancer cell lines, ATRA exerted different regulatory effects on sumoylation and ubiquitination of RARalpha. In MCF-7 cells, ATRA treatment enhanced the ubiquitination of RARalpha and the subsequent degradation of RARalpha through the ubiquitin/proteasome pathway. This resulted in a reduction in the DNA binding activity of RARalpha/retinoid X receptor alpha (RXRalpha) heterodimer, the separation of RXRalpha from RARalpha and the translocation of RXRalpha from the nucleus to the cytoplasm. By contrast, in BGC-823 cells, ATRA augmented sumoylation, not ubiquitination, of RARalpha. The stability of sumoylated RARalpha was significantly stronger than in non-sumoylated RARalpha. These results also showed an increase in the DNA binding activity of the RARalpha/RXRalpha heterodimer and the stability of nuclear localization of this heterodimer, which normally facilitates the ATRA signal transduction. In conclusion, our results reveal a novel mechanism for the regulation of RARalpha-dependent signal transduction through the ubiquitin/proteasome pathway in breast cancer cells and the sumoylation pathway in gastric cancer cells.
AuthorsQiao Wu, Xiao-feng Lin, Xiao-feng Ye, Bing Zhang, Zhong Xie, Wen-jin Su
JournalJournal of molecular endocrinology (J Mol Endocrinol) Vol. 32 Issue 3 Pg. 595-613 (Jun 2004) ISSN: 0952-5041 [Print] England
PMID15171703 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Proteasome Inhibitors
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Retinoid X Receptor alpha
  • SUMO-1 Protein
  • Polyubiquitin
  • Tretinoin
  • Proteasome Endopeptidase Complex
Topics
  • Breast Neoplasms (metabolism)
  • Cell Line, Tumor
  • Dimerization
  • Female
  • Humans
  • Polyubiquitin (metabolism)
  • Proteasome Endopeptidase Complex (metabolism)
  • Proteasome Inhibitors
  • Protein Processing, Post-Translational
  • Receptors, Retinoic Acid (chemistry, genetics, metabolism)
  • Retinoic Acid Receptor alpha
  • Retinoid X Receptor alpha (chemistry, genetics, metabolism)
  • SUMO-1 Protein (metabolism)
  • Stomach Neoplasms (metabolism)
  • Tretinoin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: